BioMed X, a biomedical research institute in Germany, is launching its first U.S. facilityin New Haven. The facility will focus on research in the areas of immunology and tissue engineering.
BioMed X has had an ongoing research collaboration with the Illinois-based pharmaceutical business AbbVie. Their first joint research project, in Germany, focused on Alzheimer’s disease.
more